Common use of IRO Review of Control Documents for Selected Physicians and/or Related Entities Clause in Contracts

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSK’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSK’s policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSK’s policies).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO in each instance as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSKForest’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician physician or Related Entity is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSKForest’s policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSKForest’s policies.).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSKBaxano Surgical’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSKBaxano Surgical’s policies were followed in connection with Payment(s) reflected Payment(s)reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSKBaxano Surgical’s policies.).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSK’s policiesNovartis’ policies and procedures; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSK’s Novartis’ policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSK’s Novartis’ policies.).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSKAmgen’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSKXxxxx’s policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSKXxxxx’s policies).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSKBIPI’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSKXXXX’s policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSKBIPI’s policies.).

IRO Review of Control Documents for Selected Physicians and/or Related Entities. For each physician and/or Related Entity selected as part of the sample, the IRO shall review the Control Documents identified by the IRO as necessary and sufficient to validate each Payment reflected in the Listing to evaluate the following: a) Whether Control Documents are available relating to each Payment reflected in the Listing for the sampled physician and/or Related Entity; b) Whether the Control Documents were completed and archived in accordance with the requirements set forth in GSKEndo’s policies; c) Whether the aggregate value of the Payment(s) as reflected in the Listing for the sampled Physician is consistent with the value of the Payments(sPayment(s) reflected in the Control Documents; and d) Whether the Control Documents reflect that GSKEndo’s policies were followed in connection with Payment(s) reflected in the Listing (e.g., all required written approvals for the activity were obtained in accordance with GSKEndo’s policies.).